Trial Profile
A retrospective study determined the efficacy of Sorafenib in patients with hepatocellular carcinoma and macrovascular invasion
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Jul 2018
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 10 Mar 2016 New trial record